Wixela vs Symbicort
What to choose Wixela or Symbicort
Wixela and Symbicort are inhalers both of Control type. Wixela and Symbicort are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Symbicort is manufactured by AstraZeneca. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6.
The average cost for Wixela is roughly $240 per inhaler while actual cost for Symbicort is roughly $359 per inhaler, said Walker Sanchez, a Postdoctoral Researcher at the Case Western Reserve Univty, Fullerton and a Surgeon at a clinic that uses Wixela and Symbicort.
Wixela and Symbicort Comparison
|Substance:||Fluticasone + Salmeterol||Budesonide + Formoterol|
|Dosage:||250/50||100/6, 160/4.5, 200/6, 400/6|